Purchases and Sales Made in Q3 2022 in Catalyst Pharmaceuticals, Inc. (CPRX)
This table provides information about the institutional ownership of Catalyst Pharmaceuticals, Inc. (CPRX) during Q3 2022. The information is specifically focused on institutions that hold shares of CATALYST PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-501K- 35.97% |
$3.53M - $7.77M
|
891K
$20.2M
|
|
|
Nov 14, 2022
Q3 2022
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-501K- 35.97% |
$3.53M - $7.77M
|
891K
$20.2M
|
|
|
Oct 26, 2022
Q3 2022
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-575K- 73.21% |
$4.06M - $8.93M
|
210K
$4.77M
|
|
|
Nov 07, 2022
Q3 2022
|
Lsv Asset Management
Chicago, IL |
SELL
|
- |
-635K- 15.76% |
$4.48M - $9.86M
|
3.39M
$76.9M
|
|
|
Nov 08, 2022
Q3 2022
|
Allianz Asset Management Gmb H
Munich, 2M |
SELL
|
- |
-648K- 62.34% |
$4.58M - $10.1M
|
392K
$8.87M
|
|
|
Nov 15, 2022
Q3 2022
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-854K- 88.27% |
$6.03M - $13.2M
|
113K
$2.57M
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.19M- 62.31% |
$8.41M - $18.5M
|
720K
$16.3M
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.19M- 62.31% |
$8.41M - $18.5M
|
720K
$16.3M
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.28M- 47.12% |
$9.06M - $19.9M
|
1.44M
$32.6M
|
|
|
Nov 03, 2022
Q3 2022
|
Royce & Associates LP
|
SELL
|
- |
-1.44M- 68.64% |
$10.2M - $22.4M
|
659K
$14.9M
|